Mammaglobin-A
Mammaglobin-A precursor (66-74) is a synthetic peptide fragment corresponding to amino acids 66 through 74 of the mammaglobin-A protein, a member of the secretoglobin family predominantly expressed in mammary tissue. This peptide sequence is of significant interest in biochemical research due to its relevance in breast tissue-specific expression and its potential as a molecular marker in various investigative contexts. The unique biochemical properties and sequence specificity of the Mammaglobin-A precursor (66-74) peptide make it a valuable tool for researchers exploring protein-protein interactions, immunological assay development, and the functional characterization of mammaglobin-A in cellular and molecular studies.
Immunological assay development: The peptide fragment serves as a well-defined antigenic epitope for the generation and validation of antibodies specific to mammaglobin-A. Researchers frequently utilize this sequence in the design of enzyme-linked immunosorbent assays (ELISA), immunoblotting, and immunohistochemistry protocols aimed at detecting mammaglobin-A expression in tissue extracts or cell lysates. Its sequence specificity enhances assay sensitivity and selectivity, facilitating the accurate quantification and localization of mammaglobin-A in experimental samples.
Epitope mapping and antibody characterization: Scientists employ the Mammaglobin-A precursor (66-74) peptide in epitope mapping studies to identify and characterize antibody binding sites on the mammaglobin-A protein. By using this defined fragment, researchers can dissect the molecular interactions between antibodies and their target antigens, supporting the development of monoclonal antibodies with high affinity and specificity. This approach is integral to advancing immunodiagnostic tools and refining antibody-based detection methods.
Protein interaction studies: The defined sequence of this peptide allows for detailed investigations into protein-protein interactions involving mammaglobin-A. By incorporating the peptide into binding assays or pull-down experiments, researchers can elucidate the molecular partners and interaction networks associated with mammaglobin-A, shedding light on its functional roles in cellular processes. Such studies contribute to a deeper understanding of signaling pathways and protein complexes in mammary tissue biology.
Biomarker research: The peptide is instrumental in studies focused on biomarker discovery and validation, particularly in the context of breast tissue differentiation and pathology. Scientists use the Mammaglobin-A precursor (66-74) fragment to evaluate its potential as a tissue-specific marker in experimental models, enabling the assessment of expression patterns and the exploration of its utility in non-clinical diagnostic research. The sequence's restricted expression profile supports its application in distinguishing mammary-derived samples from other tissue types.
Peptide-based assay calibration: The synthetic nature and defined sequence of this peptide make it an ideal standard or calibrator in quantitative peptide assays. Researchers incorporate it into mass spectrometry-based workflows, such as multiple reaction monitoring (MRM), to establish calibration curves and validate assay performance. Its use as an internal standard supports reproducibility and accuracy in quantitative proteomics and peptide quantification studies, providing robust benchmarks for experimental consistency.
Collectively, the Mammaglobin-A precursor (66-74) peptide offers a versatile platform for advancing research in immunology, molecular biology, and proteomics. Its utility spans from antibody development and epitope mapping to biomarker validation and assay calibration, making it a critical reagent for scientists investigating the molecular underpinnings of mammaglobin-A function and expression in breast tissue research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More